ZYDUSLIFE.NS
Price:
$934.4
Market Cap:
$940.23B
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, Latin America, the Asia Pacific, and Africa. The company operates in Pharmaceuticals and Consumer Products segments. It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; and products in the therapeutic areas of pain management, neurology, dermatology, liver diseases, and other areas. The company also provides consumer wellness products, such as Complan; EverYuth, a...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-07-01
Stock Exchange
NSE
Ticker
ZYDUSLIFE.NS
According to Zydus Lifesciences Limited’s latest financial reports and current stock price. The company's current ROE is 19.72%. This represents a change of 301.22% compared to the average of 4.92% of the last 4 quarters.
The mean historical ROE of Zydus Lifesciences Limited over the last ten years is 19.93%. The current 19.72% ROE has changed -1.04% with respect to the historical average. Over the past ten years (40 quarters), ZYDUSLIFE.NS's ROE was at its highest in in the September 2021 quarter at 18.55%. The ROE was at its lowest in in the September 2019 quarter at 1.04%.
Average
19.93%
Median
19.18%
Minimum
11.19%
Maximum
36.13%
Discovering the peaks and valleys of Zydus Lifesciences Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 73.91%
Maximum Annual ROE = 36.13%
Minimum Annual Increase = -57.60%
Minimum Annual ROE = 11.19%
| Year | ROE | Change |
|---|---|---|
| 2025 | 18.89% | -2.93% |
| 2024 | 19.46% | 73.91% |
| 2023 | 11.19% | -57.60% |
| 2022 | 26.40% | 60.74% |
| 2021 | 16.42% | 44.82% |
| 2020 | 11.34% | -36.29% |
| 2019 | 17.80% | -12.35% |
| 2018 | 20.31% | -4.99% |
| 2017 | 21.38% | -40.85% |
| 2016 | 36.13% | 33.52% |
The current ROE of Zydus Lifesciences Limited (ZYDUSLIFE.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
16.52%
5-year avg
18.47%
10-year avg
19.93%
Zydus Lifesciences Limited’s ROE is less than Dr. Reddy's Laboratories Limited (17.25%), less than Dr. Reddy's Laboratories Limited (17.25%), less than Lupin Limited (24.77%), less than Mankind Pharma Limited (12.74%), less than Mankind Pharma Limited (12.74%), less than Lupin Limited (24.77%), less than Aurobindo Pharma Limited (10.43%), less than Aurobindo Pharma Limited (10.43%), less than Alkem Laboratories Limited (19.01%), less than Alkem Laboratories Limited (19.01%),
| Company | ROE | Market cap |
|---|---|---|
| 17.25% | $1.06T | |
| 17.25% | $1.06T | |
| 24.77% | $958.06B | |
| 12.74% | $907.02B | |
| 12.74% | $905.01B | |
| 24.77% | $957.56B | |
| 10.43% | $701.96B | |
| 10.43% | $701.32B | |
| 19.01% | $680.80B | |
| 19.01% | $680.99B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zydus Lifesciences Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Zydus Lifesciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Zydus Lifesciences Limited's ROE?
How is the ROE calculated for Zydus Lifesciences Limited (ZYDUSLIFE.NS)?
What is the highest ROE for Zydus Lifesciences Limited (ZYDUSLIFE.NS)?
What is the 3-year average ROE for Zydus Lifesciences Limited (ZYDUSLIFE.NS)?
What is the 5-year average ROE for Zydus Lifesciences Limited (ZYDUSLIFE.NS)?
How does the current ROE for Zydus Lifesciences Limited (ZYDUSLIFE.NS) compare to its historical average?